Hubbry Logo
UltrahumanUltrahumanMain
Open search
Ultrahuman
Community hub
Ultrahuman
logo
7 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Ultrahuman
Ultrahuman
Ultrahuman
View on Wikipedia
from Wikipedia

Ultrahuman is a Bengaluru based longevity and health-monitoring platform that designs, manufactures and sells the Ultrahuman Ring Air health tracker, Ultrahuman M1 Continuous glucose monitor, pre-release Ultrahuman Home health monitor and related blood testing services like Blood vision. Ultrahuman was incorporated in 2019 by second time entrepreneurs Mohit Kumar and Vatsal Singhal. Mohit and Vatsal also co-founded Runnr in the year 2015. Runnr later merged with Zomato[1] and eventually became Zomato Food delivery.

Key Information

History

[edit]

Ultrahuman was founded by Mohit Kumar and Vatsal Singhal in 2019.[2]

Mohit Kumar, post his stint at Zomato, took a break to study martial arts at Tiger Muay Thai in Thailand. He initially observed athletes using biomarker data across streams such as glucose, HRV, blood markers etc and started designing a platform that the athletes could use to see all the data in one place. In January 2021, Ultrahuman launched its app at CES[3] in Los Angeles and Won the 'Best of CES award'. In June 2021, it launched a continuous glucose monitor called Ultrahuman M1 (formerly known as Ultrahuman Cyborg).[4]

In April 2022, Ultrahuman acquired LazyCo - a wearables IOT company.[5] LazyCo built hardware products like an AI-powered smart ring designed to predict and automate daily tasks.[6][7][8]

In June 2023, Ultrahuman won the Red Dot award at Berlin for its flagship Ultrahuman Ring Air. Ultrahuman has also raised 3 rounds of investments in the year 2020, 2022 and 2024 totalling up to $65 million. Ultrahuman claims to be EBITDA profitable and has declared its IPO plans for 2026.

2024–2025 developments

[edit]

In December 2024 the company announced the Cycle & Ovulation PowerPlug, an optional module for Ring Air that uses biomarker data to estimate fertile windows.[9]

In August 2025 Ultrahuman acquired medical device company viO HealthTech, developer of the OvuCore vaginal temperature sensor, and OvuSense fertility algorithm. The acquisition led to the launch of Cycle & Ovulation Pro, a paid version of the cycle tracking module. TechCrunch reported that the acquisition provided access to ovulation‑tracking data and allowed the company to offer more advanced cycle predictions by porting the OvuSense algorithm to the Ultrahuman Ring AIR.[10]

In July 2025, Ultrahuman launched Blood Vision, a service that offers blood testing for more than 100 biomarkers and integrates results with data from its wearables. Forbes and HLTH reported that the service initially rolled out across 48 US states.[11][12] In June 2025 the company introduced Ultrahuman Home, a device that monitors indoor air quality, temperature, humidity, noise and light.[13]

Products

[edit]
  • Ring Air – a smart ring that records sleep, movement, skin temperature and heart‑rate variability. Additional functions, including an AFib detection module that monitors heart rhythm using FibriCheck, can be enabled via optional PowerPlugs apps.[14][15]
  • M1 – a continuous‑glucose monitoring sensor and app that provides metabolic scores and nutrition guidance.
  • Ultrahuman Home – an indoor monitoring hub that records environmental factors such as air quality, temperature, humidity, noise and light.[16]
  • Blood Vision – a preventive blood‑testing service in the US, India, UAE and Saudi Arabia.[17]
  • PowerPlugs – a marketplace of mini‑applications for Ring Air; some applications are free, while others, including AFib detection and Cycle & Ovulation Pro, require a subscription.[18]

Research and patents

[edit]

In March 2024, Ultrahuman conducted a multi-armed observational study[19] which included 105 non-diabetic and pre-diabetic individuals. It aimed to show metabolic health as a continuous spectrum between non-diabetic and diabetic individuals. The clinical trial showed a correlation between its health score, 'Metabolic score', and inflammation in the body. The trial also included blood markers and gut-microbiome index markers.

The research was published in Nature Scientific Reports .[19]

Funding

[edit]

Ultrahuman has raised $65 million across three rounds of investments.

Ultrahuman raised $7.5 mn in Seed round from Nexus Venture partners and Blume ventures.[20]

In their Series A round,[21] Ultrahuman raised $17.5M in funding from Alpha Wave Incubation (AWI),[22][23] Steadview Capital, Nexus Venture Partners, Blume Ventures and iSeed fund.

In March 2024, Ultrahuman closed a US$35 million Series B funding round, comprising US$25 million in equity and the remainder in debt.[24] The round was co‑led by existing investors Blume Ventures, Steadview Capital and Nexus Venture Partners, with participation from Alpha Wave Global and Zomato founder Deepinder Goyal.[24] Ultrahuman said it would use the proceeds to increase manufacturing capacity and fund health‑tracking research.[25] TechCrunch reported that the company, which had already achieved profitability, planned to accelerate growth through the funding and aimed to achieve US$100 million in annualized revenue run rate by the end of 2024.[26]

UltraFactory

[edit]

Ultrahuman opened its first UltraFactory in Bengaluru in 2022. It partnered with the U.S. electronics manufacturer SVTronics and opened a factory in Plano, Texas.[27] HBW Insight reported that the company maintains offices in London, India and the United Arab Emirates and sells its products through more than 150 retail outlets worldwide.[28]

References

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Ultrahuman

View on Grokipedia
from Grokipedia
Ultrahuman is an Indian company founded in 2019 by Mohit Kumar and Vatsal Singhal, focused on developing wearable devices and software platforms to monitor and optimize metabolic health, , recovery, and longevity. The company's flagship product, the Ultrahuman Ring AIR, is a lightweight smart ring that tracks metrics such as , blood oxygen levels, skin temperature, and movement to provide insights into quality, stress, and daily expenditure without relying on screens or vibrations. Ultrahuman's ecosystem extends beyond the ring to include the M1 for real-time metabolic tracking, Blood Vision for analyzing over 100 blood biomarkers, and a Home Monitor for factors like air quality and noise. These tools integrate into a unified app that delivers personalized recommendations to enhance performance, particularly for athletes and individuals pursuing preventive health strategies. Headquartered in Bengaluru with additional offices in and , Ultrahuman has grown to approximately 300 employees as of 2025 and has raised over $60 million in funding from investors including Nexus Venture Partners and Alpha Wave Global. In 2025, the company achieved profitability with $64 million in revenue for FY25 and acquired viO HealthTech to expand its medical device offerings. The company emphasizes data-driven , partnering with professional teams like UAE Team Emirates to optimize athletic recovery and has expanded into tracking for cycles and . Its mission centers on empowering users to achieve peak vitality through accessible, non-invasive monitoring, positioning it as a leader in the consumer health wearables market.

Overview

Founding and Leadership

Ultrahuman was founded in 2019 by Mohit Kumar and Vatsal Singhal in Bengaluru, , as a startup specializing in non-invasive health monitoring solutions. The company was incorporated as Ultrahuman Healthcare Private Limited, operating as a privately held entity under Indian law. Mohit Kumar serves as the CEO, bringing experience from prior entrepreneurial ventures and operational leadership in the tech sector. He previously co-founded Runnr, a logistics platform in 2015 that merged with in 2017, where he later held roles including COO of . Vatsal Singhal, the co-founder and CTO, contributes expertise in product and engineering, with a background in information science engineering and prior roles at as Associate Vice President and Head of Product and Engineering for its listing business; his hardware experience stems from co-founding LazyCo, a wearables IoT startup acquired by Ultrahuman in 2022. The leadership team has expanded to support global operations, with key hires including Bhuvan Srinivasan as in 2021, a former KKR executive tasked with driving international expansion. Board members include the founders Mohit Kumar and Vatsal Singhal, alongside advisors such as , a digital health pioneer. As of 2025, the executive structure remains focused on the founding duo, with additional strategic advisors like Dr. Philip Ovadia contributing to metabolic guidance. Initially starting with a small core team, Ultrahuman has established operational hubs in Bengaluru (headquarters), , and to facilitate its international presence and product development.

Mission and Core Focus

Ultrahuman's core mission is to empower individuals to optimize their through deeply personalized insights and real-time guidance derived from continuous monitoring of key physiological metrics. The company aims to build the future of preventive health by providing innovative tools that track , recovery, metabolic fitness, glucose levels, and environmental factors, enabling users to enhance their performance and vitality without invasive methods. This approach positions Ultrahuman as a longevity platform, focusing on non-invasive, real-time data to support holistic across physical and mental dimensions. What sets Ultrahuman apart from competitors like Oura is its commitment to a subscription-free model for core health insights, ensuring users access essential data without ongoing fees, while emphasizing privacy through secure, non-shared health information practices. The platform integrates AI-driven analytics to deliver tailored coaching and actionable nudges, transforming raw biometric data into practical recommendations for better sleep, recovery, and metabolic health. This privacy-centric, user-owned data model, backed by SOC 2 certification, prioritizes ethical handling of sensitive information. Ultrahuman targets a diverse audience, including athletes, biohackers, and everyday wellness enthusiasts, with a particular emphasis on women's health through specialized cycle tracking and fertility insights. Partnerships with professional teams like Team UAE Emirates highlight its appeal to performance-driven users seeking precise, non-intrusive monitoring. The company's strategic pillars revolve around hardware innovation for accurate sensing, advanced data analytics for personalization, and ecosystem development that integrates wearables with home health tools to foster comprehensive metabolic and recovery tracking. By 2024, women comprised 44% of its user base, reflecting growing adoption among those prioritizing hormonal and reproductive health metrics.

Products and Services

Ultrahuman Ring Air

The Ultrahuman Ring Air, launched in June 2023, is a lightweight designed for continuous monitoring without the need for screens or ongoing subscriptions. Constructed from fighter jet-grade reinforced with a carbon coating, it weighs as little as 2.4 grams, making it one of the lightest wearables available and prioritizing all-day comfort for users. The ring tracks key biometric including , (HRV), stages, , and movement, using like photoplethysmography (PPG) for heart metrics, a 6-axis motion , and a non-contact . This design aligns with Ultrahuman's mission to enable proactive monitoring through unobtrusive, finger-based sensing that offers higher accuracy due to increased blood flow compared to wrist devices. Key features include the PowerPlugs platform, which delivers modular software updates to enhance functionality, such as (AFib) detection powered by FDA-cleared FibriCheck technology for nocturnal heart rhythm monitoring and advanced cycle tracking for menstrual phase predictions. The companion app, available for and Android, provides AI-driven insights like the Movement Index—which evaluates daily activity based on metabolic equivalents (METs) and frequency rather than just volume—and the Recovery Score, calculated from factors including sleep quality, HRV, resting , stress, and trends to guide rest and performance decisions. Battery life lasts up to 6 days on a single charge, with full recharging in about 2-3 hours, supporting seamless, extended wear. In terms of design specifications, the Ring Air is available in sizes 5 through 14, with a sizing kit provided for accurate fit, and offers color options such as Raw , Aster Black, and Bionic . It features 10 water resistance, rated for up to 100 meters, allowing use during or showering. Initially priced at $349, the device has no variants explicitly named "SRE" documented in , though color and finish updates have been introduced. By fiscal year 2025, Ultrahuman reported over $61 million in revenue from Ring Air sales, indicating strong user adoption. The ring's accuracy has been validated in clinical studies, showing high concordance for sleep against devices like the and medical-grade tools, with PPG-based metrics aligning closely to ECG standards for detection. In October 2025, a U.S. court ruled that the Ring Air infringes on patents, halting new sales in the United States effective October 21, 2025, though support for existing units and retailer sales of remaining inventory continue.

Additional Offerings

Ultrahuman offers the M1, a continuous glucose monitoring system that provides real-time insights into metabolic by tracking glucose levels through a minimally invasive arm-worn that inserts a filament under the skin. Launched in the in February 2024 after earlier availability in markets like and the since 2021, the M1 integrates with the Ultrahuman app to analyze the impacts of factors such as alcohol consumption and intake on glucose responses, delivering personalized recommendations for diet and activity. This data combines with metrics from the Ring Air to generate comprehensive reports, emphasizing metabolic optimization without requiring ongoing subscriptions for core features. Complementing personal wearables, Ultrahuman introduced the Home device in January 2024, a stationary monitor designed for living spaces. It tracks key indoor factors including air quality, temperature, humidity, noise levels, and various light spectrums (such as blue light and UV), syncing this information with Ring Air data to offer holistic wellness insights on how surroundings affect , recovery, and overall performance. In October 2025, Ultrahuman launched Vision Cloud, a free AI-powered tool within the app that interprets reports from blood tests and other lab results. Users can upload documents for instant analysis of biomarkers, trend identification, and actionable advice, enhancing preventive monitoring. Accompanying this is the $99 Blood Vision Essentials kit, an at-home testing option for key markers like and vitamins, further broadening access to diagnostic services. The Ultrahuman app serves as the central software ecosystem, featuring community challenges for motivation, guided coaching programs for nutrition and fitness, and an enabling third-party integrations for seamless data sharing. Unlike many competitors, it operates without mandatory subscriptions, providing all essential insights at no recurring cost. Ultrahuman has forged partnerships to expand its reach, including integrations with Apple Health for effortless data syncing across devices. By , the company had collaborated with retailers to distribute products through over 150 outlets worldwide, such as Verizon stores in the and in , facilitating broader consumer access.

History

Early Development

Ultrahuman's early development began with pre-2020 ideation, where founders Mohit Kumar and Vatsal Singhal, leveraging their software background from co-founding the logistics startup Runnr, identified significant gaps in wearable health technology. Initially focused on software solutions for fitness and performance tracking, they pivoted to hardware amid the heightened health awareness during the COVID-19 pandemic, recognizing the need for more accurate, non-invasive devices to monitor metabolic and vital metrics beyond traditional wearables like smartwatches. This shift was driven by personal experiences in sports and martial arts, where data-driven insights from biomarkers proved essential for optimization, inspiring a move toward building integrated hardware-software ecosystems for broader health applications. Between 2020 and 2021, the company advanced prototype development in its Bengaluru headquarters, securing initial resources to iterate on hardware designs. The focus centered on a compact ring form factor to enable discreet, continuous monitoring of key health indicators such as , temperature, and movement, addressing limitations in bulkier devices. Initial beta testing provided feedback on and data reliability, helping refine the prototype's integration of sensors for real-time metabolic insights while maintaining a lightweight, screen-free design. This phase marked Ultrahuman's transition from a software-first fitness platform—launched in 2019 with features like workout videos and third-party device integration—to pioneering proprietary wearables. Development faced notable challenges, including global disruptions for specialized sensors exacerbated by the , which delayed component sourcing and assembly in India's nascent hardware ecosystem. Early accuracy tuning for metrics like blood oxygen saturation (SpO2) required extensive iterations to minimize errors from motion artifacts and skin tone variations, ensuring clinical-grade reliability without invasive methods. These hurdles were overcome through rigorous in-house testing and collaborations with sensor suppliers, validating the ring's potential for everyday use in tracking recovery and stress. The culmination of this phase came with Ultrahuman's first public reveal on in October 2022, transitioning from to commercial preparation and showcasing the ring prototype to global audiences. This debut highlighted the device's innovative approach to metabolic health tracking, positioning the company for market entry and attracting early interest from investors and users seeking alternatives to dominant wearables.

Key Milestones and Expansions

In 2023, Ultrahuman achieved significant growth with the launch of its flagship Ultrahuman Ring AIR, a lightweight designed for continuous monitoring of , movement, , and recovery metrics, marking a pivotal advancement in its wearable portfolio. The company also expanded its international presence by entering European markets, including partnerships with retailers such as in , which facilitated broader accessibility for consumers seeking non-invasive tracking solutions. This period saw the company's user base grow substantially, reflecting increased adoption amid rising demand for personalized insights. Building on this momentum, 2024 brought a major funding milestone with Ultrahuman securing $35 million in Series B financing from investors including Blume Ventures, enabling accelerated product development and global retail expansion. The capital supported the introduction of enterprise-focused offerings, such as enhanced versions of the Ring AIR tailored for organizational wellness programs, alongside the establishment of a U.S.-based manufacturing facility in to localize production and mitigate challenges. Retail distribution grew to over 150 outlets worldwide, strengthening the company's footprint in key markets like the and . By 2025, Ultrahuman continued its expansion with the October release of Vision Cloud, an AI-powered platform integrated into its app that provides free interpretation of reports, including tests, to democratize access to medical . The company also launched the Ultrahuman Home device in June, a stationary sensor for monitoring environmental factors like air quality, light, and noise to optimize home wellness. In January 2025, Ultrahuman launched the Rare, a luxury crafted from 18K and , at CES 2025. Retail partnerships expanded further, reaching more than 200 outlets globally, including major U.S. chains like , where the Ring AIR became available for direct purchase. However, in October 2025, following an ITC ruling on claims by Oura, Ultrahuman faced a U.S. import ban on its current s, prompting plans for a new ring design and continued support for existing users. Amid these developments, Ultrahuman reported achieving profitability in FY25 with revenue surpassing $64 million, positioning it on a trajectory toward status as it targets sustained high-growth in the tech sector.

Research and Development

Patents and Innovations

Ultrahuman has filed a total of 54 patents globally by 2025, with 16 granted and 35 active, primarily in (13) and the (19), focusing on advancements in for metabolic tracking and AI algorithms for prediction. Ultrahuman's IP strategy emphasizes defensive filings to safeguard core technologies in wearables like the Ring Air, with three patents licensed to partners to foster ecosystem-wide adoption of compatible monitoring standards.

Scientific Research and Collaborations

Ultrahuman has conducted several internal validation studies between 2022 and 2025 to assess the accuracy of its wearable devices, particularly focusing on and metabolic tracking. For instance, a 2023 pilot study compared tracking concordance between the Ultrahuman Ring AIR (finger-based) and a popular wrist-based wearable, revealing differences in awake episode detection, with the Ring AIR recording longer awake periods compared to the wrist-based device. Another study evaluated sensing by the Ring AIR against an and an FDA-approved (SleepImage), demonstrating strong overlap in measurements during , with mean absolute errors below 5 bpm across participants. These studies emphasize data-driven refinements to algorithms, though direct comparisons to remain limited in published internal reports. The company has contributed to peer-reviewed literature, including a 2024 publication in the Journal of the Endocrine Society detailing an on metabolic health using the Ultrahuman M1 (CGM) in non- and pre-diabetic South Asians. This multi-armed study, involving 200 participants aged 25-50, correlated glycemic variability metrics from the M1 CGM with activity data from wearables like , highlighting how lifestyle factors influence insulin sensitivity in diverse populations and providing baseline glycemic indices for this demographic. Ultrahuman engages in academic collaborations to advance health research. In 2025, it partnered with Lehigh University's Department of Bioengineering to equip female athletes with Ring AIR devices, aiming to study physiological responses for injury prevention and address menstrual health taboos through real-world data collection. This initiative, involving 13 participants, leverages the ring's sensors for tracking recovery and hormonal cycles, fostering interdisciplinary insights into women's wellness. Earlier efforts include joint observational work underlying the M1 CGM study, conducted with clinical oversight to validate device outputs in population-specific contexts. As part of its data initiatives, Ultrahuman supports open health research by anonymizing aggregated user data from its platforms, with contributions evident in the 2024 Journal of the Endocrine Society study on metabolic health in South Asian cohorts. This approach enables broader scientific analysis of glucose patterns across demographics, promoting equitable insights without individual identification. Ethical considerations underpin Ultrahuman's research, with trials adhering to (IRB) approvals and emphasizing informed user consent. For example, the company's cycle tracking validation study obtained ethical clearances from relevant boards, ensuring participants understood data usage for algorithm training. Bias mitigation in AI models involves efforts through balancing and protocols to minimize demographic skews in outputs for global users.

Funding and Financials

Investment Rounds

Ultrahuman's funding journey began with a seed round in 2020, where it raised $7.5 million from Blume Ventures and Nexus Venture Partners to advance prototype development for its wearable health monitoring devices. The company followed this with a in August 2021, securing $17.5 million led by Global (formerly Alpha Wave Incubation), with additional participation from Blume Ventures and individual investors. This round valued Ultrahuman at approximately $100 million and supported product iteration and market entry. In March 2024, Ultrahuman announced a $35 million Series B round, comprising $25 million in equity and $10 million in debt, led by Steadview Capital with involvement from Mayfield, Blume Ventures, Nexus Venture Partners, Alpha Wave Global, and co-founder Deepinder Goyal. At this point, the company's cumulative funding reached about $60 million, enabling scaling of manufacturing and global expansion. By September 2025, Ultrahuman's total stood at approximately ₹472 (around $56 million), reflecting ongoing investor confidence amid its profitability milestone.

Valuation and Revenue Growth

Ultrahuman's valuation has shown steady progression aligned with its milestones and operational scaling. Following its in August 2021, which raised $17.5 million, the company's was not publicly disclosed at the time, though subsequent rounds built on early momentum. The Series B round in March 2024, raising $35 million (including $25 million in equity and $10 million in debt), elevated the to approximately $125 million, reflecting investor confidence in its portfolio. By April 2025, Ultrahuman entered advanced discussions for a new round targeting $100-120 million from WestBridge Capital and others, potentially valuing the company at $500-550 million post-money, positioning it closer to status though the round remained in progress as of late 2025. Revenue growth has been a key driver of Ultrahuman's financial trajectory, with the company achieving a fivefold increase in fiscal year 2025 (ending March 2025). Operational revenue reached ₹565 crore (approximately $68 million) in FY25, up from ₹105 crore ($12.6 million) in FY24, marking a 438% year-over-year surge fueled by expanded direct-to-consumer sales and retail partnerships. This followed a 15-fold revenue expansion from ₹7 crore in FY22 to ₹105 crore in FY24, driven primarily by demand for its flagship Ring Air smart ring, which accounted for 91% of FY25 revenue at ₹516 crore. Subscription features contributed 5.1% (₹29 crore), while other operating income, including ancillary hardware like the Ultrahuman Home monitoring device, made up the remainder. The company targeted ₹1,100 crore ($132 million) in revenue for FY26, supported by an annualized run-rate of $150-160 million reported mid-2025 and a shift toward higher-margin recurring subscriptions. Ultrahuman transitioned to profitability in FY25, posting a net profit of ₹73 ($8.8 million) after a ₹38 loss in FY24, with EBITDA margins at 8.76% underscoring healthy operational efficiency on hardware sales. Early stages featured some bootstrapped elements alongside seed funding, but the company has since relied on without reporting significant beyond the Series B component. This financial health, bolstered by 35% retail sales contribution in (up from 20% in 2023) and growing enterprise deals, positions Ultrahuman for sustained expansion in the competitive wearables market.

Manufacturing and Operations

UltraFactory Facilities

Ultrahuman's original manufacturing hub, the UltraFactory in Bengaluru, was established in 2022 as the company's primary production site for its wearable devices, particularly the smart rings. The facility incorporates automated assembly lines designed specifically for ring production, capable of supporting up to $200 million in annual revenue as of 2024. This setup supports the end-to-end manufacturing process, from component assembly to final packaging, ensuring efficient scaling to meet global demand. The facility integrates advanced technologies to enhance precision and efficiency, including robotic systems for sensor calibration during assembly. AI-driven systems monitor production in real time. Capacity at the Bengaluru UltraFactory has seen substantial growth, driven by investments in and optimizations. This scaling allows for personalized customizations, such as engravings on rings, without compromising turnaround times. The facility played a key role in supporting major product launches, including the Ring AIR, by ramping up output to align with market rollout timelines. To ensure compliance with international standards, acquired entities such as viO HealthTech hold ISO 13485 certification for medical device manufacturing, which covers quality management systems essential for exporting health-monitoring wearables to regulated markets worldwide.

Global Supply Chain and Retail Expansion

Ultrahuman's global supply chain strategy emphasizes a hybrid model combining facilities in India and the United States to optimize production, reduce import dependencies, and ensure faster delivery to international markets. The company's core manufacturing operations are based in Bengaluru, India, where it handles significant portions of assembly and production for its wearable devices, including the Ring AIR smart ring. This setup allows for efficient scaling while leveraging local expertise in electronics manufacturing. To mitigate risks from global disruptions, such as supply delays or regulatory hurdles, Ultrahuman has pursued vertical integration in key areas like continuous glucose monitoring (CGM) production, which it brought in-house in Bengaluru to improve margins and control quality. A pivotal aspect of this expansion occurred in April 2024, when Ultrahuman announced the establishment of its first U.S.-based UltraFactory in Plano, Texas, marking the production of the company's initial American-made wearables. Set to open within six months of the announcement, the facility began operations in November 2024 with an initial capacity of 200,000 smart rings annually, targeting North American demand and unlocking an estimated $100 million in additional revenue. By May 2025, Ultrahuman expanded the Texas plant's output to over 500,000 units per year, aiming to fulfill 100% of U.S. orders domestically and shorten shipping times for customers in the region. This move not only addresses logistical bottlenecks but also positions the company to better serve its growing U.S. market, which constitutes a substantial portion of its global sales. In parallel, Ultrahuman has evolved its retail distribution from a (D2C) focus to a multichannel approach, blending online with physical retail partnerships to enhance . In 2024, D2C channels accounted for 41% of , while retail contributed 35%, up from 20% the previous year, reflecting a deliberate shift to diversify streams. The company maintains a strong online presence through its and Amazon storefront, but has expanded into brick-and-mortar outlets, including availability in select Verizon stores across the U.S. starting August 2024 and Costco locations starting August 2025, where the Ring AIR is offered at competitive pricing. Internationally, products like the limited-edition Rare variant are sold in select retail stores in and , with plans for further rollout to cities such as New York and . This strategy supports broader accessibility while maintaining control over brand experience. Logistically, Ultrahuman faces challenges from barriers and regulatory issues, prompting adaptations in its fulfillment network. Following a U.S. International Trade Commission (ITC) import ban effective October 2025—as of September 2025 determination—due to a dispute with competitor Oura, the company accelerated reliance on its facility to meet 50-60% of U.S. demand initially with redesigned products compliant with local standards. Ultrahuman filed an appeal against the ban in October 2025. This domestic production helps circumvent import restrictions, ensuring continuity in fulfillment through partners and direct channels, while minimizing delays for global customers. The Bengaluru hub continues to support , coordinating with fulfillment centers to handle customs and shipping across regions.

References

  1. https://tracxn.com/d/companies/ultrahuman/__RSGzV5aJJQdyE6IBruBLiGXE7STOO3AfA1qtqw5Z4zo
  2. https://pitchbook.com/profiles/company/458417-44
  3. https://www.ultrahuman.com/
  4. https://www.crunchbase.com/organization/ultrahuman
  5. https://www.bwdisrupt.com/article/ultrahuman-reports-rs-565-cr-revenue-turns-profitable-in-fy25-572502
  6. https://cyborg.ultrahuman.com/press-releases/ultrahuman-delivers-record-fy25-profits-as-subscription-engine-accelerates
  7. https://thekredible.com/company/ultrahuman/overview
  8. https://yourstory.com/companies/ultrahuman
  9. https://tracxn.com/d/legal-entities/india/ultrahuman-healthcare-private-limited/__y4wSDx5o89EMso5ZWuCjYWlk26U6W73MQJF9y_N54Hw
  10. https://www.livemint.com/companies/start-ups/healthtech-wearable-startup-ultrahuman-raises-17-5-million-in-funding-11629180451304.html
  11. https://ae.linkedin.com/in/mohit-kumar-1014a326
  12. https://ae.linkedin.com/in/singhal-vatsal
  13. https://memfault.com/resources/building-and-scaling-a-startup-in-the-ultra-competitive-health-wearables-market/
  14. https://m.economictimes.com/tech/startups/healthtech-startup-ultrahuman-acquires-wearables-firm-lazyco/articleshow/90797821.cms
  15. https://www.nasdaq.com/press-release/ultrahuman-hires-former-kkr-exec-ahead-of-expansion-drive-2021-10-18
  16. https://thekredible.com/company/ultrahuman/financials
  17. https://www.ultrahuman.com/advisors/joel
  18. https://www.ultrahuman.com/advisors/phil
  19. https://inc42.com/company/ultrahuman/
  20. https://blog.ultrahuman.com/blog/ultrahuman-raises-17-5-mn-series-a/
  21. https://www.wired.com/story/ultrahuman-prime-day-2025/
  22. https://www.nbcnews.com/select/shopping/ultrahuman-ring-air-review-rcna202789
  23. https://cyborg.ultrahuman.com/press-releases/ultrahuman-launches-vision-cloud
  24. https://www.instagram.com/p/DN-9BifAWkl/
  25. https://www.ultrahuman.com/womens-health/
  26. https://entrackr.com/news/ultrahuman-reports-rs-620-cr-revenue-in-2024-8652508
  27. https://cyborg.ultrahuman.com/press-releases/ultrahuman-unveils-an-ultra-comfortable-fitness-wearable-the-ultrahuman-ring-air
  28. https://www.ultrahuman.com/ring/
  29. https://www.ultrahuman.com/powerplugs/
  30. https://cyborg.ultrahuman.com/press-releases/ultrahuman-announces-its-app-store-powerplugs-with-the-worlds-first-afib-detection-technology-on-a-smart-ring
  31. https://blog.ultrahuman.com/blog/ultrahuman-ring-recovery-score-guide/
  32. https://www.instagram.com/p/Cu6gksSIr0U/
  33. https://www.ultrahuman.com/ring/buy/us
  34. https://www.ultrahuman.com/ring/faq/
  35. https://www.ultrahuman.com/ring/buy/global/
  36. https://news.startupro.in/fitness-ring-maker-ultrahuman-becomes-profitable-in-fy25-with-5x-revenue-growth/
  37. https://science.ultrahuman.com/studies/sleep-heart-rate-sensing
  38. https://techcrunch.com/2024/07/16/ultrahumans-smart-ring-gets-fda-approved-afib-detection/
  39. https://blog.ultrahuman.com/blog/ultrahuman-is-here-for-long/
  40. https://www.techradar.com/health-fitness/the-ultrahuman-m1-continuous-glucose-monitor-finally-gets-its-long-awaited-us-launch
  41. https://wearable-technologies.com/news/ultrahumans-cgm-hits-us-market
  42. https://blog.ultrahuman.com/blog/ultrahuman-m1-a-game-changer-for-metabolic-health-in-india/
  43. https://blog.ultrahuman.com/blog/ultrahuman-revolutionizes-home-health-with-the-launch-of-ultrahuman-home/
  44. https://athletechnews.com/ultrahuman-targets-the-next-frontier-in-wellness-your-home/
  45. https://blog.ultrahuman.com/blog/introducing-vision-cloud/
  46. https://blog.ultrahuman.com/blog/accessing-the-ultrahuman-partnership-api/
  47. https://www.wired.com/review/ultrahuman-ring-air/
  48. https://blog.ultrahuman.com/blog/how-to-access-your-hrv-data-on-apple-health/
  49. https://cyborg.ultrahuman.com/press-releases/made-in-the-usa-ultrahuman-plants-flag-in-us-with-manufacturing-facility-ultrafactory-to-make-first-wearable-rings-in-the-country
  50. https://www.forbes.com/sites/davidprosser/2021/08/17/how-ultrahuman-is-moving-from-sports-science-to-global-healthcare/
  51. https://lucidityinsights.com/podcasts-masterclasses/startup-spotlights-s1e02
  52. https://techcrunch.com/2021/08/16/ultrahuman-raises-17-5m-touting-a-wearable-blood-glucose-tracker/
  53. https://www.ajuniorvc.com/ultrahuman-unicorn-case-study-product-performance-hardware-oura-ring-review
  54. https://insights.citeline.com/MT154619/Ultrahuman-Expands-Wearable-Medtech-Production-Into-US-After-%2435M-Funding-Round/
  55. https://techcrunch.com/2024/03/20/ultrahuman-series-b/
  56. https://www.healthtechdigital.com/made-in-the-usa-ultrahuman-plants-flag-in-us-with-manufacturing-facility-ultrafactory-to-make-first-wearable-rings-in-the-country/
  57. https://www.globenewswire.com/news-release/2025/06/06/3095095/0/en/Ultrahuman-Home-The-Future-of-Healthy-Living-is-here.html
  58. https://www.healthtechdigital.com/ultrahuman-unveils-rare-the-worlds-first-luxury-smart-ring-at-ces-2025/
  59. https://www.bestbuy.com/site/searchpage.jsp?id=pcat17071&st=ultrahuman%2Bring
  60. https://insights.greyb.com/ultrahuman-healthcare-patents/
  61. https://science.ultrahuman.com/studies/wrist-based-vs-finger-based-sleep-tracking
  62. https://pmc.ncbi.nlm.nih.gov/articles/PMC10948749/
  63. https://engineering.lehigh.edu/news/article/wearable-tech-advance-women-s-health
  64. https://science.ultrahuman.com/studies/cycle-tracking-pro-accuracy
  65. https://www.vccircle.com/nexusbacked-wearable-startup-ultrahuman-secures-35-mn-in-equity-debt
  66. https://finance.yahoo.com/news/ultrahuman-raises-35m-accelerate-growth-130000226.html
  67. https://thekredible.com/company/ultrahuman/funding
  68. https://m.economictimes.com/tech/funding/ultrahuman-in-talks-with-westbridge-to-raise-100-120-million-after-softbank-deal-falls-through/articleshow/120691700.cms
  69. https://entrackr.com/fintrackr/ultrahuman-income-jumps-15x-to-rs-107-cr-in-two-fiscal-years-8645920
  70. https://pulse.d2cinsider.com/ultrahuman-targets-e2-82-b91100-crore-revenue-in-fy26-eyes-global-scale/
  71. https://m.economictimes.com/tech/startups/wearable-startup-ultrahuman-turns-profitable-in-fy25-revenue-jumps-fivefold/articleshow/124041926.cms
  72. https://entrackr.com/fintrackr/ultrahuman-reports-rs-565-cr-revenue-and-rs-73-cr-profit-in-fy25-10485974
  73. https://cyborg.ultrahuman.com/press-releases/ultrahuman-acquires-vio
  74. https://www.biospectrumindia.com/news/90/24537/ultrahuman-plants-flag-in-us-with-manufacturing-facility-to-make-wearable-rings.html
  75. https://www.globenewswire.com/news-release/2025/05/08/3077389/0/en/Ultrahuman-Expands-its-American-Factory-s-Manufacturing-Capacity.html
  76. https://mashable.com/article/ultrahuman-ring-us-factory-expansion
  77. https://athletechnews.com/ultrahuman-expands-u-s-presence/
  78. https://www.costco.com/p/-/ultrahuman-ring-air-raw-titanium-smart-ring-charger-included/4000354773
  79. https://inc42.com/buzz/after-us-import-ban-ultrahuman-plans-redesigned-smart-ring/
  80. https://tech.yahoo.com/wearables/articles/oura-fight-ultrahuman-just-had-163646580.html
  81. https://gadgetsandwearables.com/2025/10/26/ultrahuman-appeal/
Add your contribution
Related Hubs
User Avatar
No comments yet.